Parkinson’s Disease

Parkinson´s disease is a progressive neurodegenerative disorder.

Our products in development

“I have an ethical responsibility to contribute to Infudopa becoming available to patients suffering from Parkinson’s disease”

– Arvid Carlsson (1923-2018) who received the Nobel prize in 2000 for the discoveries that paved the way for the introduction of levodopa as treatment for Parkinson´s disease.

Report from the General Meeting in Dizlin Pharmaceuticals AB

Dizlin Pharmaceuticals held a General Meeting on May 28, 2020. The ordinary board members Leif Bring, Staffan Schüberg, Elias Eriksson, Anders Stenström and Nil Dizdar were re-elected. Anders Tullgren, Åsa Hansdotter and Johan von Heijne [...]

Clinical update

Researchers at Sahlgrenska Academy, in Gothenburg, Sweden, have finalized the pivotal clinical pharmacokinetic trial where Infudopa SubC™ and Infudopa IntraV™ have been compared with Duodopa®/Duopa® with respect to serum levodopa levels in 18 patients with [...]

Dizlin Pharmaceuticals appoints Chief Commercial Officer

Henrik Martinsson has been appointed CCO of Dizlin Pharmaceuticals and he joined the company on October 1st. Henrik Martinsson has worked 20 years in the medical device business, mostly for Abbott in different roles. Most [...]

Read all news